论文部分内容阅读
目的探讨急性心肌棱无心血管内科患者的临床治疗方法。方法随机抽取某一指定的调查医院在2015年5月到2016年5月期间收治的50例急心肌梗死患者的临床资料进行回顾性分析,根据护理方法的不同,将患者平均分为两组,对照组(25例)和观察组(25例),其中,对照组给予常规护理,观察组则在对照组的基础上加以给予尿激酶,针对两组患者的护理效果进行评价分析。结果经过一段时间(一般2个月)护理治疗后,两组患者的症状均得到缓解,其中对照组有效的18例,无效的7例,总有效率为72%;观察组有效的有24例,无效的有1例,总有效率为96%。两组都无死亡病例,没有出现并发症,且两组疗效具有显著差异,具有统计学意义。结论对急性心肌梗死心血管内科患者采取尿激酶治疗后疗效显著,能够有效确保患者的生命安全,实现患者疾病的有效康复。
Objective To investigate the clinical treatment of acute myocardial infarction patients without cardiology. Methods The clinical data of 50 patients with acute myocardial infarction admitted from a designated survey hospital from May 2015 to May 2016 were retrospectively analyzed. According to the different nursing methods, the patients were divided into two groups at random, Control group (25 cases) and observation group (25 cases). The control group was given routine nursing. The observation group was given urokinase on the basis of the control group, and the nursing effect of the two groups was evaluated. Results After a period of care (usually 2 months), the symptoms of both groups were relieved, of which 18 cases were effective in the control group and 7 cases were ineffective, with a total effective rate of 72%. In the observation group, 24 cases were effective , 1 case of invalid, the total effective rate was 96%. No deaths were found in both groups, no complication occurred, and there was significant difference between the two groups with statistical significance. Conclusion The curative effect of urokinase on patients with acute myocardial infarction and cardiovascular medicine is significant, which can effectively ensure the life safety of patients and achieve effective rehabilitation of patients’ diseases.